Work

Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000–01 FFCD/SFRO study

Year: 2008

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Annals of Oncology

DOI: 10.1093/annonc/mdn281

Authors: B. Chauffert, F. Mornex, F. Bonnetain, P. Rougier, C. Mariette, O. Bouché, J.F. Bosset, T. Aparicio, L. Mineur, A. Azzedine, P. Hammel, J. Butel, N. Stremsdoerfer, P. Maingon, L. Bedenne

Institutions: Centre Georges François Leclerc, Hôpital Lyon Sud, Fédération Francophone de Cancérologie Digestive, Hôpital Ambroise-Paré, Centre Hospitalier Universitaire de Lille, Centre Hospitalier Universitaire de Reims, Centre Hospitalier Universitaire de Besançon, Hôpital Bichat-Claude-Bernard, Institut Sainte Catherine, Hôpital Beaujon

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2172089182

FWCI: 19.33

Cites: 29

Cited by: 706

Related to: 10